Biometrics & DataMay 15, 2026

HRV in Women: How Hormones Shape Heart Rate Variability Across the Menstrual Cycle and Menopause

By Sameer Sontakey

This guide reviews research on HRV across the menstrual cycle and menopause, including measurement limits and the importance of individual context.

Updated: May 15, 2026

Quick answer: hrv menstrual cycle interpretation should account for changing ovarian hormones, symptoms, sleep, temperature, and training load across the cycle. Many users show lower HRV in the luteal phase or around menstruation, but individual baselines matter more than a universal phase rule.

hrv menstrual cycle

This article reviews third-party research on hormonal context and HRV, rather than a Sensor Bio Device application.

Verification checklist

Document phase definitions and recording conditions; do not label a change normal or abnormal from cycle phase alone.
Track sleep, symptoms, temperature, and training load alongside HRV.
Treat menopause, hormonal contraception, and cycle irregularity as separate analysis contexts.

Authoritative sources

A 2019 systematic review and meta-analysis found an average reduction in cardiac vagal activity from the follicular to luteal phase, with substantial differences in methods and phase comparisons.11 This is a group-level association, not a deterministic rule for an individual reading. The sections below discuss study methods, hormonal context, and measurement limitations.

What HRV measures and why sex matters

Heart rate variability (HRV) quantifies variation in intervals between successive heartbeats. SDNN summarizes the spread of normal-to-normal intervals, while RMSSD summarizes successive interval differences. HF power is often used as a measure of vagally mediated variability, with breathing and recording conditions affecting interpretation.1 LF/HF is a ratio of spectral components whose physiological interpretation is limited; it is not a direct measure of sympathovagal balance.12

Population reference values cannot determine why an individual reading changed. The Nunan review summarizes short-term HRV values across studies, not phase-specific diagnostic thresholds. Research comparisons should distinguish recording methods and hormonal context rather than infer that every follicular reading exceeds a population average or every luteal reading falls below it.7

Hormonal context and limits of application

Contraceptive method, pregnancy or postpartum status, and menopause may change the context of HRV research. These populations should not be pooled without an appropriate study design. The studies listed here do not establish HRV-guided training, diagnosis, risk assessment, or treatment monitoring.

Studies of hormonal context and autonomic physiology do not establish a consumer wearable as a tool to assess PCOS, postpartum mood disorders, menopause-related cardiovascular risk, or response to hormone therapy. Decisions about symptoms and treatment require independent clinical assessment.

HRV across the menstrual cycle: follicular, ovulatory, and luteal phases

Cycle-phase definitions and confirmation methods matter: fixed calendar days do not describe every cycle. Sato et al. assessed 20 women in follicular and luteal phases across two cycles; the study examined baseline and mental-challenge recordings, not 24-hour HRV.2 Yildirir et al. compared recordings in follicular and luteal windows in 43 women, rather than measuring a brief ovulatory sympathetic transient.4

Bai et al. examined nonlinear HRV properties across menstrual phases. Such comparisons do not establish a universal day-by-day RMSSD trajectory or identify the hormonal cause of an individual change.3

Study	Phase comparison	Finding and limit	Citation
Sato et al.	Follicular vs. luteal	Lower baseline HF and higher LF in the luteal phase; not a universal RMSSD rule	2
Yildirir et al.	Follicular vs. luteal	Higher LF/HF in the luteal phase; absolute LF and HF did not differ significantly	4
Schmalenberger et al.	Meta-analysis of within-person phase comparisons	Average follicular-to-luteal reduction in cardiac vagal activity; heterogeneous methods and comparisons	11

LF/HF differences should not be interpreted as direct measurements of sympathetic–parasympathetic balance.12

Hormonal mechanisms: how estrogen and progesterone drive autonomic tone

Estrogen has cardiovascular effects, including effects on vascular function, discussed in the review by Mendelsohn and Karas.5 That mechanistic background does not establish that hormone levels or their ratio determine an individual HRV value, energy level, or recovery speed.

Phase-associated HRV differences should be described at the level actually measured. The reviewed comparisons do not establish a hormone-ratio rule for the magnitude of RMSSD suppression, nor do they show that a low reading is harmless solely because it occurs in the luteal phase.11

HRV and menopause: autonomic changes during perimenopause and postmenopause

Huikuri et al. studied sex differences in 186 middle-aged women and 188 men and also compared women using estrogen therapy with age-matched women not using it. That design does not establish an individual menopause trajectory, a pre-symptom circadian HRV warning sign, or reductions in every HRV metric caused by estrogen withdrawal.6

Stein et al. compared younger and older adults. Among women, older age was associated mainly with lower short-term HRV indices, without significant changes in circadian variability.8 These between-group comparisons should not be presented as longitudinal menopause-onset evidence or a wearable treatment-response test.

Measurement methodology: when and how to measure HRV in women

Recording duration, posture, time of day, respiration, beat selection, and artifact handling should be specified for HRV research.1 Cycle-phase definitions and confirmation methods should also be reported, rather than assigning phase solely from a calendar day.9

Recent exercise, sleep, substances, medications, ambient conditions, and hormonal context can overlap. A phase tag helps describe a recording; it does not establish why HRV changed or supply a clinical interpretation of a particular RMSSD value.

PPG vs ECG: signal-level trade-offs for cycle-resolved HRV tracking

ECG remains the gold standard for HRV measurement. It detects the electrical depolarization wavefront at the QRS complex, providing R-R intervals with millisecond-level precision. Short-term and 24-hour Holter protocols based on ECG underpin the normative database for HRV, including all foundational cycle-phase studies cited in this article.1 When a study reports that RMSSD is significantly higher in the follicular phase than the luteal phase, that finding is built on ECG-derived R-R interval data collected under controlled conditions. That provenance matters when evaluating what PPG-based monitoring can and cannot tell you.

Photoplethysmography (PPG) derives pulse intervals from a peripheral vascular waveform rather than cardiac electrical activity. Pulse arrival timing includes vascular and pre-ejection effects, so pulse intervals are not identical by definition to ECG R-R intervals. The studies cited here do not establish a universal luteal-phase direction of PPG HRV bias.

Recording duration, missing data, motion, vascular timing, and measurement error depend on the device and protocol. Agreement with ECG must be evaluated for the metric and conditions being studied; it cannot be assumed from cycle phase.

Limits and pitfalls when interpreting HRV data in women

Population reference values and phase averages do not establish an individual diagnosis. A study should report recording conditions and phase definitions rather than classify a low reading as either abnormal or harmless from cycle context alone.7 9

A 2019 systematic review and meta-analysis found an average reduction in cardiac vagal activity from the follicular to luteal phase, with substantial differences in methods and phase comparisons. Its standardized effects do not establish a universal change in RMSSD measured in milliseconds.11

An HRV change cannot identify its cause. Cycle phase, breathing, vascular timing, sleep, illness, activity, and measurement artifacts may overlap. Record context without assigning a diagnosis or a cycle phase from these signals alone.

Practical interpretation limits

A concurrent temperature shift does not let a reader classify an HRV dip as ovulation rather than stress or incomplete recovery. Repeated phase-matched observations may help describe a pattern, but they cannot isolate its cause. The cited evidence does not establish an automatic app flag as clinically useful or a three-day HRV decline as evidence of illness or fatigue.

Optical artifacts can distort HRV in either direction. Research analysis should inspect signal quality and document exclusions rather than equate a noisy recording with low HRV.

Consumer wearable HRV is not established here as a method for capturing hot flashes, assessing menopause-related cardiovascular risk, monitoring postpartum mood disorders, or evaluating hormone-therapy response. Decisions about symptoms and treatment require independent clinical assessment.

References

Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart Rate Variability: Standards of Measurement, Physiological Interpretation, and Clinical Use. Circulation. 1996;93(5):1043-1065. PMID: 8598068. Source
Sato N, Miyake S, Akatsu J, Kumashiro M. Power spectral analysis of heart rate variability in healthy young women during the normal menstrual cycle. Psychosomatic Medicine. 1995;57(4):331-335. PMID: 7480562. DOI: 10.1097/00006842-199507000-00004
Bai X, Li J, Zhou L, Li X. Influence of the menstrual cycle on nonlinear properties of heart rate variability in young women. American Journal of Physiology: Heart and Circulatory Physiology. 2009;297(2):H765-H774. PMID: 19465541. DOI: 10.1152/ajpheart.01283.2008
Yildirir A, Kabakci G, Akgul E, Tokgozoglu L, Oto A. Effects of menstrual cycle on cardiac autonomic innervation as assessed by heart rate variability. Annals of Noninvasive Electrocardiology. 2002;7(1):60-63. PMID: 11844293. DOI: 10.1111/j.1542-474X.2001.tb00140.x
Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. New England Journal of Medicine. 1999;340(23):1801-1811. PMID: 10362825. DOI: 10.1056/NEJM199906103402306
Huikuri HV, Pikkujamsa SM, Airaksinen KE, Ikaheimo MJ, Rantala AO, Kauma H, Lilja M, Kesaniemi YA. Sex-related differences in autonomic modulation of heart rate in middle-aged subjects. Circulation. 1996;94(2):122-125. PMID: 8674168. DOI: 10.1161/01.CIR.94.2.122
Nunan D, Sandercock GR, Brodie DA. A quantitative systematic review of normal values for short-term heart rate variability in healthy adults. Pacing and Clinical Electrophysiology. 2010;33(11):1407-1417. PMID: 20552350. DOI: 10.1111/j.1540-8159.2010.02841.x
Stein PK, Kleiger RE, Rottman JN. Differing effects of age on heart rate variability in men and women. American Journal of Cardiology. 1997;80(3):302-305. PMID: 9264423. DOI: 10.1016/S0002-9149(97)00350-0
Schmalenberger KM, Tauseef HA, Barone JC, Owens SA, Lieberman L, Jarczok MN, Girdler SS, Kiesner J, Ditzen B, Eisenlohr-Moul TA. How to study the menstrual cycle: Practical tools and recommendations. Psychoneuroendocrinology. 2021;123:104895. PMID: 33113391. DOI: 10.1016/j.psyneuen.2020.104895
Dekker JM, Crow RS, Folsom AR, Hannan PJ, Liao D, Swenne CA, Schouten EG. Low heart rate variability in a 2-minute rhythm strip predicts risk of coronary heart disease and mortality from several causes: the ARIC Study. Circulation. 2000;102(11):1239-1244. PMID: 10982537. DOI: 10.1161/01.CIR.102.11.1239
Schmalenberger KM, Eisenlohr-Moul TA, Würth L, et al. A Systematic Review and Meta-Analysis of Within-Person Changes in Cardiac Vagal Activity across the Menstrual Cycle: Implications for Female Health and Future Studies. J Clin Med. 2019;8(11):1946. PMID: 31726666. DOI: 10.3390/jcm8111946 Source
Billman GE. The LF/HF ratio does not accurately measure cardiac sympatho-vagal balance. Front Physiol. 2013;4:26. DOI: 10.3389/fphys.2013.00026 Source

FAQ

Does HRV actually change across the menstrual cycle?

A 2019 systematic review and meta-analysis found an average reduction in cardiac vagal activity from the follicular to luteal phase. Methods and phase comparisons differed across studies. This group-level result does not establish a universal RMSSD change in milliseconds or the cause of an individual reading.[11]

Which HRV metrics are most sensitive to menstrual cycle phase?

RMSSD and HF power are commonly used measures of vagally mediated HRV, but their interpretation depends on breathing and recording conditions. The cited studies do not establish a universal ranking for phase sensitivity. LF/HF is a ratio of spectral components whose physiological interpretation is limited; it is not a direct measure of sympathovagal balance.1

How does menopause affect HRV?

Age and hormonal context need to be distinguished. Huikuri et al. studied sex differences in middle-aged adults and compared women using estrogen therapy with age-matched women not using it. This was not a longitudinal study of menopause onset or estrogen withdrawal and does not establish an individual menopause trajectory or cardiovascular-risk warning sign.[6]

Can HRV be used to predict or identify menstrual cycle phase?

An HRV change cannot identify cycle phase or its cause. Cycle phase, breathing, vascular timing, sleep, illness, activity, and measurement artifacts may overlap. Record context without assigning a diagnosis or cycle phase from HRV and temperature signals alone. Group-level phase associations do not establish individual classification accuracy.

Are standard HRV reference ranges valid for women of reproductive age?

Population reference values depend on the cohorts, metrics, and recording methods used. The Nunan review does not provide a phase-specific threshold for an individual woman. It should not be used to classify a reading as normal or pathological solely from cycle day. Research comparisons should document phase definitions and relevant recording conditions.[7]

How should a single HRV reading be interpreted in cycle context?

A single reading cannot establish its cause or an individual health status. Comparable repeated recordings and documented cycle context can help a research analysis, but there is no universal three-to-five-reading rule or cycle-day-specific RMSSD threshold established by the studies cited here. Symptoms and treatment decisions require independent clinical assessment.

Does HRV differ between premenopausal and postmenopausal women?

Differences between age or hormonal groups should not be read as a within-person menopause trajectory. Huikuri et al. compared middle-aged women and men and an estrogen-therapy subgroup; Stein et al. compared younger and older adults, not a prospective menopause transition. These designs do not show that circadian HRV flattening precedes symptoms or that every metric falls because of estrogen withdrawal.6